Founded in 2002 and headquartered in Seattle, WA, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate Therapeutics has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE®) to specifically regulate signaling and metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-invasive device called EMulate Therapeutics Voyager.
The company’s goal is to transform disease treatment on a global scale with ulRFE®. The proprietary technology has the potential to be applied to a wide range of conditions as well as veterinary medicine and non-medical applications.
EMulate Therapeutics’ initial focus is on the treatment of patients with brain cancer who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Additional pre-clinical work is focused on exploring new applications in oncology and pain treatment.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Seattle, Wa 98109, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://emulatetx.com/
- Keywords
- Medical Device.
- HQ
- Seattle, WA
Emulate Therapeutics, Inc. Questions
Emulate Therapeutics, Inc.'s website is https://emulatetx.com/
Emulate Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/emulatetherapeutics
Emulate Therapeutics, Inc. has
12 employees.
View email and phone details for 12
employees at Emulate Therapeutics, Inc..
Emulate Therapeutics, Inc.'s industry is
Biotechnology Research
Emulate Therapeutics, Inc.'s top competitors are
Irhythm Technologies, Inc.,
Notch Therapeutics,
Myosana Therapeutics, Inc,
Deverra Therapeutics,
Atossa Therapeutics, Inc.,
Magenta Therapeutics,
Ignyte Bio,
Emulate, Inc.,
Voyager Therapeutics, Inc.,
Monte Rosa Therapeutics.
Emulate Therapeutics, Inc.'s categories are Biotechnology Research
Emulate Therapeutics, Inc.'s founding year is 2002
